Pharmacology & Toxicology · 1991 · 21 citations · 18 references
MedicineMedicinal ChemistryPharmacologyDrug InteractionsNeuropharmacologyPharmacodynamicsCholinergic PharmacologyNeurochemical PharmacologyAcute Drug ToxicityCatechol-o-methyltransferase InhibitionCatechol-o-methyltransferase PathwaysIntraperitoneal AdministrationPharmacodynamics Of Neuroactive DrugsPharmacological PotencyPharmacological SpecificityToxic Dose Assessment
3-Nitropyrocatechols are very potent and selective inhibitors of catechol-O-methyltransferase (COMT). LD50 values of three of these compounds were assessed after intraperitoneal administration with a special emphasis on interactions with drugs increasing catecholaminergic neurotransmission. LD50 values of the inhibitors varied from 137 mg/kg (Ro 41-0960) to 507 mg/kg (OR-462) and 544 mg/kg (OR-611). The LD50 value of Ro 41-0960 was significantly lower than that of OR-462 and OR-611 (P less than 0.05). At toxic dose levels all inhibitors caused convulsions and hypomotility. OR-462 and OR-611 had statistically significant mortality increasing interaction with 20 mg/kg of nomifensine (P less than 0.05) and the former also with 10 mg/kg of amphetamine (P less than 0.05). Owing to their high therapeutic indexes these compounds can be considered useful new tools in pharmacological research.
18
Goodman and Gilman's the Pharmacological Basis of Therapeutics
William H. Stigelman, D Pharm · Military Medicine · 1986 · 6.8K citations
Neuropsychopharmacology of monoamines and their regulatory enzymes.
Lipton Ma · PubMed · 1974 · 416 citations
Medicine, Neuroscience, Pharmacology +10